Ionis Pharmaceuticals Inc... (IONS)

NASDAQ: IONS · Real-Time Price · USD

31.79

1.08 (3.52%)

At close: May 01, 2025, 3:59 PM

31.30

-1.54%

Pre-market: May 02, 2025, 07:11 AM EDT

Ionis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	242.08M	399.27M	1.99B	2.12B	1.89B	2.5B	2.08B	1.02B	665.22M
Short-Term Investments	2.06B	1.93B	1.71B	1.25B	1.49B	1.82B	1.81B	893.09M	2.41M
Long-Term Investments	n/a	42.99M	40.37M	15.62M	15.06M	-331.23M	-314.83M	n/a	n/a
Other Long-Term Assets	127.28M	62.29M	34.63M	59.99M	51.06M	358M	327.74M	10.13M	1.32M
Receivables	92.19M	97.78M	25.54M	61.9M	76.2M	63.03M	12.76M	62.95M	108.04M
Inventory	12.51M	28.43M	22.03M	24.81M	21.96M	18.18M	8.58M	9.98M	7.49M
Other Current Assets	217.93M	184.45M	157.72M	125.17M	140.16M	130.62M	102.47M	73.08M	17.18M
Total Current Assets	2.62B	2.64B	2.2B	2.35B	2.13B	2.72B	2.21B	1.17B	797.93M
Property-Plant & Equipment	256.11M	242.94M	256M	178M	181M	154M	132.16M	121.91M	92.84M
Goodwill & Intangibles	n/a	n/a	n/a	29M	27.94M	25.67M	24.03M	22M	20.36M
Total Long-Term Assets	383.38M	348.22M	331M	267M	260M	512M	459.9M	154.04M	114.53M
Total Assets	3B	2.99B	2.53B	2.61B	2.39B	3.23B	2.67B	1.32B	912.47M
Account Payables	42.96M	26.03M	17.92M	11.9M	17.2M	16.07M	28.66M	24.89M	21.12M
Deferred Revenue	78.99M	151.13M	91M	98M	108M	118M	160.26M	106.47M	51.28M
Short-Term Debt	n/a	53.16M	7.54M	3.53M	308.81M	2.03M	13.75M	1.62M	1.19M
Other Current Liabilities	187.33M	147.89M	140.1M	88.56M	73.03M	66.77M	48.36M	125.34M	24.19M
Total Current Liabilities	309.32M	448.09M	312M	241M	290M	273M	280.29M	224.74M	133.78M
Long-Term Debt	1.25B	1.74B	1.18B	1.16B	623.53M	725.59M	573.13M	546.09M	515.56M
Other Long-Term Liabilities	860.52M	n/a	n/a	67.09M	n/a	44.68M	54.93M	167.8M	n/a
Total Long-Term Liabilities	2.11B	2.16B	1.65B	1.6B	1.26B	1.27B	1.2B	678.56M	679.12M
Total Liabilities	2.42B	2.6B	1.96B	1.84B	1.55B	1.55B	1.48B	903.3M	812.9M
Total Debt	1.42B	1.45B	1.34B	1.16B	749M	710M	568.22M	533.11M	500.63M
Common Stock	158K	144K	142K	141K	140K	140K	138K	125K	122K
Retained Earnings	-2.25B	-1.8B	-1.43B	-1.16B	-1.25B	-707.53M	-967.29M	-1.19B	-1.18B
Comprehensive Income	-30.81M	-32.65M	-57.48M	-32.67M	-21.07M	-25.29M	-32.02M	-31.76M	-30.36M
Shareholders Equity	588.35M	386.69M	573M	772M	843M	1.47B	1.05B	330.87M	99.56M
Total Investments	2.06B	1.98B	1.71B	1.25B	1.49B	1.82B	1.81B	893.09M	2.41M